P.E.T.Net and UCLA sign molecular imaging pact

Radiopharmaceutical provider P.E.T.Net Pharmaceuticals of Knoxville, TN has signed a licensing agreement with the University of California, Los Angeles, for development rights to molecular imaging probes for the COX-2 enzyme.

P.E.T.Net, a subsidiary of Knoxville, TN-based CTI Molecular Imaging, and UCLA collaborated in establishing the L.A. Tech Center in 2001 to study molecular therapeutics. COX-2 is an enzyme that causes inflammatory disorders, and UCLA is researching the enzyme.

By AuntMinnie.com staff writers
November 4, 2002

Related Reading

P.E.T.Net, Nelson join to market PET, September 26, 2002

PET firm CTI files for IPO, April 12, 2002

P.E.T.Net opens new radiopharmacies, November 15, 2001

Focus on PET pays off for CTI as modality booms, August 6, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 435
Next Page